Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Biopharmaceuticals Emerging as a Focus for Contract Manufacturing Market

Feb 14, 2011
Share |
 
According to our latest research offering Global Contract Manufacturing Market Analysis, biopharmaceutical segment is the recent focus of the pharma contract manufacturing industry. This segment, despite the impact of the recent economic downturn, has been growing at a stupendous rate. However, the segment has been concerned regarding the high production costs of products, like vaccines, monoclonal antibodies, and other biological treatment products. Hence, the biopharmaceutical companies are resorting to outsource of their manufacturing work. The report further revealed an even positive future growth outlook for the industry, which is poised to grow at a CAGR of 11% by 2013. .
 
The report comprises a detail study regarding the prevailing market scenario in the prominent developed and developing contract manufacturing countries around the world. It also provides a list of key players and the direction being followed by the industry in the respective countries. Additionally, the report covers the export condition of active pharmaceutical products (API) and the finished drugs in the prominent countries.
 
Our report “Global Contract Manufacturing Market Analysis”, also comprises key market trends and competitive landscape. The competitive landscape segment provides information regarding the business overview, recent developments, strengths and weaknesses of top global contract manufacturing companies. The key market trends enumerated in the report provide balanced outlook of the industry and identify factors, which would lead the growth of the industry in near future. Additionally, the report has a descriptive account of the current issues at hand, which are having an impact on the industry. This would allow the clients to identify the most prevailing loopholes in the industry and also pragmatic solutions for overcoming them.
 
Analysis of the ongoing developments, market expectations, and driving factors facilitates clear market intelligence. Apart from the current market scenario, the forecasting in the report provides a clear picture of the industry’s future. The report would help clients in enhancing their understanding regarding the industry and thereby, formulating strategies to help their business grow.

For more information visit: http://www.rncos.com/Report/IM265.htm

Related Press Releases:
» US Generic Drugs to Grow Strongly in Future
» FDI Fuelling Growth of Hospital Services in India
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports